Brannin McBee - 15 Feb 2025 Form 4 Insider Report for CoreWeave, Inc. (CRWV)

Signature
/s/ Kristen McVeety, as Attorney-in-Fact
Issuer symbol
CRWV
Transactions as of
15 Feb 2025
Transactions value $
-$5,579,525
Form type
4
Filing time
03 Jun 2025, 18:00:42 UTC
Next filing
27 Mar 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McBee Brannin Chief Development Officer C/O COREWEAVE, INC., 290 WEST MT. PLEASANT AVENUE, SUITE 4100, LIVINGSTON /s/ Kristen McVeety, as Attorney-in-Fact 03 Jun 2025 0002058103

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRWV Class A Common Stock Options Exercise $0 +109K $0.00 109K 31 May 2025 Direct
transaction CRWV Class A Common Stock Tax liability -$5.58M -50.1K -45.84% $111.31 59.2K 31 May 2025 Direct F1
transaction CRWV Class A Common Stock Conversion of derivative security +5.44K 5.44K 15 Feb 2025 Direct F2, F3
transaction CRWV Class A Common Stock Conversion of derivative security +5.44K 5.44K 15 Feb 2025 Direct F2, F3
transaction CRWV Class A Common Stock Gift $0 -5.44K -100% $0.00 0 15 Feb 2025 Direct F2, F4
transaction CRWV Class A Common Stock Gift $0 -5.44K -100% $0.00 0 15 Feb 2025 By Spouse F2, F4, F5
transaction CRWV Class A Common Stock Gift $0 +640 +55.17% $0.00 1.8K 15 Feb 2025 See Footnote F2, F4, F6
holding CRWV Class A Common Stock 60K 15 Feb 2025 Canis Major SM Trust F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRWV Restricted Stock Units Options Exercise $0 -109K -6.25% $0.00 1.64M 31 May 2025 Class A Common Stock 109K Direct F8, F9, F10
transaction CRWV Restricted Stock Units Award $0 +188K $0.00 188K 13 Mar 2025 Class A Common Stock 188K Direct F2, F8, F10, F11, F12
transaction CRWV Class B Common Stock Conversion of derivative security -5.44K -0.03% 17.7M 15 Feb 2025 Class A Common Stock 5.44K Direct F2, F3, F13
transaction CRWV Class B Common Stock Conversion of derivative security -5.44K -0.16% 3.41M 15 Feb 2025 Class A Common Stock 5.44K By Spouse F2, F3, F5, F13
transaction CRWV Restricted Stock Units Award $0 +1.75M $0.00 1.75M 31 Dec 2024 Class A Common Stock 1.75M Direct F2, F8, F10, F11, F14
holding CRWV Class B Common Stock 11.6M 15 Feb 2025 Class A Common Stock 11.6M Direct F3
holding CRWV Class B Common Stock 104K 15 Feb 2025 Class A Common Stock 104K Canis Major 2025 Family Trust LLC F3, F15
holding CRWV Class B Common Stock 114K 15 Feb 2025 Class A Common Stock 114K Canis Minor 2025 Family Trust LLC F3, F16
holding CRWV Class B Common Stock 6M 15 Feb 2025 Class A Common Stock 6M Canis Major 2025 GRAT F3, F17
holding CRWV Class B Common Stock 360K 15 Feb 2025 Class A Common Stock 360K Canis Major 2024 Irrevocable Trust F3, F18
holding CRWV Class B Common Stock 2.3M 15 Feb 2025 Class A Common Stock 2.3M By Spouse F3, F5
holding CRWV Class B Common Stock 6.67M 15 Feb 2025 Class A Common Stock 6.67M Brannin J. McBee 2022 Irrevocable Trust F3, F19
holding CRWV Class B Common Stock 1M 15 Feb 2025 Class A Common Stock 1M Canis Minor 2025 GRAT F3, F20
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of the Issuer's Class A Common Stock that have been withheld by the Issuer to satisfy its income tax liabilities in connection with the net settlement of restricted stock units.
F2 The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), in connection with the Issuer's initial public offering ("IPO"), and the transaction is reported herein pursuant to Rule 16a-2(a). All numbers of shares and prices set forth in this Form 4 have been adjusted to reflect a one for twenty forward stock split of all classes of the Issuer's capital stock effected on March 14, 2025.
F3 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
F4 On February 15, 2025, the reporting person and his spouse each transferred as gifts, for no consideration, shares of the Issuer's Class A Common Stock. The transactions represent gifts which are exempt pursuant to Rule 16b-5. With the exception of 320 of such shares gifted by each of the reporting person and his spouse to their minor child, the gifts were made to individuals outside the reporting person's household and such pre-IPO transactions represent reductions in the reporting person's direct and indirect beneficial ownership.
F5 The reported securities are directly held by the reporting person's spouse.
F6 The reported securities are directly held of record by the reporting person's minor child.
F7 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.
F8 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.
F9 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche was scheduled to vest on March 31, 2025, but settlement was deferred pursuant to a duly taken action of the compensation committee of the Issuer's board of directors.
F10 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.
F11 This restricted stock unit award represents an equity security previously reported on the reporting person's Form 3, which was acquired through an exempt transaction with the Issuer.
F12 The award was granted subject to a performance-based vesting condition which was satisfied in connection with the Issuer's IPO, as well as a service-based vesting schedule. The award shall vest as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.
F13 For clarity, on February 28, 2025, the reporting person subsequently made a contribution of 6,000,000 shares of the Issuer's Class B Common Stock to the Major GRAT (defined below) and a capital contribution of 104,000 shares of Class B Common Stock to the Major LLC (defined below), and his spouse made a contribution of 1,000,000 shares of the Issuer's Class B Common Stock to the Minor GRAT (defined below) and a capital contribution of 114,000 shares of Class B Common Stock to the Minor LLC (defined below). The reporting person believes that these transfers constituted a change in the form of beneficial ownership without changing the reporting person's pecuniary interest in the shares, and are exempted from reporting by Rule 16a-13 under the Exchange Act.
F14 The award was granted subject to a performance-based vesting condition which was satisfied in connection with the Issuer's IPO, as well as a service-based vesting schedule. The award vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vesting on March 31, 2025. Notwithstanding the aforementioned vesting schedule, settlement of the vested portion of the award has been deferred pursuant to an amendment approved by the compensation committee of the Issuer's board of directors.
F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC (the "Major LLC"), of which the reporting person serves as manager.
F16 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC (the "Minor LLC"), of which the reporting person serves as manager.
F17 The reported securities are directly held by the Canis Major 2025 GRAT (the "Major GRAT"), of which the reporting person is the sole trustee and beneficiary.
F18 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust (fka, the Meghan Q. Bennett 2024 Delaware Family Trust) (the "Irrevocable Trust"), of which the reporting person and his minor child are beneficiaries. Pursuant to the constitutive documents of the Irrevocable Trust, the reporting person serves as its investment adviser and as such exercises voting and investment discretion over securities held by the Irrevocable Trust. Additionally, the reporting person's spouse has the power to remove and replace the Irrevocable Trust's third-party trustee.
F19 The reported securities are directly held by the Brannin J. McBee 2022 Irrevocable Trust, of which the reporting person's spouse and minor child are beneficiaries and for which the reporting person's spouse serves as trustee.
F20 The reported securities are directly held by the Canis Minor 2025 GRAT (the "Minor GRAT"), of which the reporting person's spouse is the sole beneficiary and trustee.